REFERENCES
- Greenhill, J. P.: Obstetrics. Ed. 11. Philadelphia, W. B. Saunders Company, 1955, p. 367.
- Council on Pharmacy and Chemistry, American Medical Association: Quote. J.A.M.A. 160:208, 1956.
- Beecher, H. K.: The powerful placebo. J.A.M.A. 159: 1602, 1955.
- Galli-Mainini, C.: Pregnancy test using the male Batrachia. J.A.M.A. 138:121, 1948.
- Smith, Kline and French Laboratories: Thorazine Reference Manual. Philadelphia, Smith, Kline and French Laboratories, 1956, p. 2.
- McCulloch, W. S., Graf, C. and Magoun, H. W.: Cortico-bulbo reticular pathways from area 4-s. J. Neurophysiol. 9:127–132, 1946.
- Rhines, R. and Magoun, H. W.: Brain stem facilitation of cortical motor response. J. Neurophysiol. 9: 219–229, 1946.
- Benaron, H. B. and Others: The use of chlorpromazine in the obstetrical patient in the treatment of nausea and vomiting of pregnancy. Am. J. Obst. & Gynec. 69:776 (April) 1955.
- Menguy, R., Bollman, J., Grindlay, J. and Cain, J.: Biliary stasis produced by chlorpromazine. Proc. Staff Meet., Mayo Clin. 30:601, 1955.
- Sussman, R. and Summer, P.: Jaundice following the administration of 50 mg. of chlorpromazine. New England J. Med. 253:449, 1955.
- Doughty, R. B.: The incidence of jaundice associated with chlorpromazine therapy. In: Chlorpromazine and Mental Health. Philadelphia, Lea it Febiger, 1955.
- Bartholomew, L.: Chlorpromazine hepatitis without clinical jaundice. Proc. Stag Meet., Mayo Clin. 31:201, 1956.